Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Area of Science:

• Oncology
• Medical Guidelines

Background:

• Non-small cell lung cancer (NSCLC) management has evolved with longer survival for metastatic patients.
• Targeted therapies and immunotherapies have significantly impacted treatment outcomes.
• The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) are a crucial resource for cancer care.

Purpose of the Study:

• To present a focused selection of the NCCN Guidelines for NSCLC.
• To highlight recommended targeted therapies for metastatic NSCLC patients with actionable mutations.

Main Methods:

• Review and synthesis of current NCCN Guidelines for NSCLC.
• Focus on treatment recommendations for specific patient populations.

Main Results:

• Identification of key targeted therapies for metastatic NSCLC based on actionable mutations.
• Emphasis on improved survival associated with these targeted treatments.

Conclusions:

• Targeted therapies are integral to the management of metastatic NSCLC.
• Adherence to NCCN Guidelines ensures optimal, evidence-based treatment selection for NSCLC patients with actionable mutations.